Idexx Laboratories
IDXX
1,000 hedge funds and large institutions have $30.6B invested in Idexx Laboratories in 2022 Q4 according to their latest regulatory filings, with 164 funds opening new positions, 331 increasing their positions, 355 reducing their positions, and 68 closing their positions.
141% more first-time investments, than exits
New positions opened: 164 | Existing positions closed: 68
33% more funds holding in top 10
Funds holding in top 10: 18 → 24 (+6)
27% more capital invested
Capital invested by funds: $24B → $30.6B (+$6.58B)
8% more funds holding
Funds holding: 924 → 1,000 (+76)
0.39% more ownership
Funds ownership: 88.53% → 88.92% (+0.39%)
7% less repeat investments, than reductions
Existing positions increased: 331 | Existing positions reduced: 355
14% less call options, than puts
Call options by funds: $152M | Put options by funds: $177M
Top Buyers
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$130M |
| 2 |
Morgan Stanley
New York
|
+$101M |
| 3 |
Winslow Capital Management
Minneapolis,
Minnesota
|
+$80.9M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$62.2M |
| 5 |
JP Morgan Chase
New York
|
+$46.5M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$128M |
| 2 |
BlackRock
New York
|
-$112M |
| 3 |
Fundsmith LLP
London,
United Kingdom
|
-$68.7M |
| 4 |
Principal Financial Group
Des Moines,
Iowa
|
-$60.6M |
| 5 |
DDC
DF Dent & Co
Baltimore,
Maryland
|
-$57M |
IDXX Hedge Fund Activity: Q4 2022 in Review
1,000 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2022, worth a combined $30.6B — up 27% from $24B a quarter earlier.
Buyers outnumbered sellers: 164 funds opened new IDXX positions and 68 closed out — a net gain of 96 holders — while 331 added to existing stakes and 355 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $130M. The largest seller was Fidelity Investments, cutting an estimated $128M.
- 1,000 institutional investors held Idexx Laboratories (IDXX) as of Q4 2022, up from 924 in Q3 2022.
- Funds reported $30.6B of Idexx Laboratories stock for Q4 2022, up 27% quarter-over-quarter.
- 164 funds opened new Idexx Laboratories positions in Q4 2022 and 68 closed out, a net change of +96 holders.
- The largest Idexx Laboratories buyer in Q4 2022 was AllianceBernstein, an estimated $130M added.
- The largest Idexx Laboratories seller in Q4 2022 was Fidelity Investments, an estimated $128M sold.
Based on aggregated 13F filings for Q4 2022.